Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Antigen, T-Cell, alpha-beta | 44 | 2024 | 805 | 7.720 |
Why?
|
Receptors, Antigen, T-Cell | 131 | 2024 | 2540 | 6.490 |
Why?
|
T-Lymphocytes | 237 | 2023 | 10180 | 4.320 |
Why?
|
Major Histocompatibility Complex | 40 | 2024 | 936 | 3.730 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 68 | 2008 | 906 | 3.410 |
Why?
|
Thymus Gland | 54 | 2022 | 1267 | 3.080 |
Why?
|
Mechanotransduction, Cellular | 11 | 2023 | 541 | 2.580 |
Why?
|
HIV Envelope Protein gp41 | 15 | 2023 | 314 | 2.570 |
Why?
|
Epitopes, T-Lymphocyte | 20 | 2021 | 880 | 2.270 |
Why?
|
Peptides | 44 | 2024 | 4409 | 2.180 |
Why?
|
Receptors, Immunologic | 51 | 1997 | 1423 | 2.150 |
Why?
|
Antigens, Surface | 91 | 2021 | 1663 | 2.070 |
Why?
|
Lymphocyte Activation | 107 | 2017 | 5524 | 2.070 |
Why?
|
Histocompatibility Antigens | 12 | 2024 | 471 | 1.860 |
Why?
|
T-Lymphocytes, Cytotoxic | 30 | 2018 | 1821 | 1.770 |
Why?
|
Histocompatibility Antigens Class II | 28 | 2021 | 1475 | 1.720 |
Why?
|
Amino Acid Sequence | 111 | 2021 | 13815 | 1.610 |
Why?
|
Influenza A virus | 8 | 2015 | 456 | 1.590 |
Why?
|
T-Lymphocyte Subsets | 14 | 2017 | 1838 | 1.580 |
Why?
|
Molecular Sequence Data | 112 | 2015 | 18111 | 1.380 |
Why?
|
Histocompatibility Antigens Class I | 10 | 2022 | 1366 | 1.320 |
Why?
|
Ligands | 28 | 2023 | 3282 | 1.290 |
Why?
|
Epitopes | 43 | 2023 | 2571 | 1.290 |
Why?
|
Complementarity Determining Regions | 3 | 2016 | 149 | 1.280 |
Why?
|
Antigens, Neoplasm | 21 | 2023 | 1988 | 1.220 |
Why?
|
Antigens, Viral | 11 | 2014 | 1035 | 1.210 |
Why?
|
Models, Molecular | 53 | 2019 | 5456 | 1.200 |
Why?
|
CD8-Positive T-Lymphocytes | 18 | 2023 | 4479 | 1.120 |
Why?
|
HLA-A Antigens | 5 | 2011 | 231 | 1.090 |
Why?
|
H-2 Antigens | 11 | 2004 | 366 | 1.080 |
Why?
|
Protein Conformation | 42 | 2019 | 4011 | 1.070 |
Why?
|
Antigen Presentation | 15 | 2019 | 1284 | 1.030 |
Why?
|
Immunodominant Epitopes | 4 | 2008 | 267 | 1.020 |
Why?
|
Protein Multimerization | 6 | 2018 | 970 | 0.960 |
Why?
|
HLA Antigens | 22 | 2017 | 1381 | 0.950 |
Why?
|
Antibodies, Monoclonal | 114 | 2016 | 9274 | 0.930 |
Why?
|
Protein Binding | 40 | 2024 | 9386 | 0.920 |
Why?
|
Membrane Glycoproteins | 26 | 2021 | 3768 | 0.920 |
Why?
|
Antigens, CD | 23 | 2017 | 4026 | 0.890 |
Why?
|
Peptide Fragments | 24 | 2021 | 5097 | 0.880 |
Why?
|
HIV Antibodies | 11 | 2023 | 1322 | 0.880 |
Why?
|
Antigens, Differentiation | 15 | 1995 | 927 | 0.860 |
Why?
|
HIV-1 | 17 | 2023 | 6939 | 0.860 |
Why?
|
Mice | 134 | 2023 | 81183 | 0.840 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 10 | 2024 | 507 | 0.840 |
Why?
|
Glycoproteins | 16 | 2018 | 2263 | 0.830 |
Why?
|
Antigens | 20 | 2023 | 1466 | 0.820 |
Why?
|
AIDS Vaccines | 8 | 2022 | 938 | 0.810 |
Why?
|
Cell Dedifferentiation | 1 | 2022 | 135 | 0.810 |
Why?
|
HIV Envelope Protein gp120 | 14 | 2013 | 952 | 0.800 |
Why?
|
Protein Structure, Secondary | 15 | 2021 | 1246 | 0.790 |
Why?
|
Interleukin-2 | 42 | 2007 | 1904 | 0.790 |
Why?
|
Animals | 200 | 2024 | 168757 | 0.770 |
Why?
|
Gene Products, env | 6 | 2005 | 263 | 0.770 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 3 | 2021 | 342 | 0.740 |
Why?
|
Protein Structure, Tertiary | 25 | 2014 | 3846 | 0.730 |
Why?
|
HLA-A2 Antigen | 8 | 2019 | 213 | 0.710 |
Why?
|
B-Lymphocytes | 44 | 2018 | 4665 | 0.680 |
Why?
|
Cell Adhesion | 19 | 2018 | 3144 | 0.670 |
Why?
|
Molecular Dynamics Simulation | 2 | 2024 | 413 | 0.660 |
Why?
|
Cell Membrane | 20 | 2019 | 3748 | 0.660 |
Why?
|
Signal Transduction | 42 | 2021 | 23403 | 0.640 |
Why?
|
Cytoskeletal Proteins | 6 | 2018 | 1364 | 0.620 |
Why?
|
Cell Differentiation | 44 | 2017 | 11483 | 0.620 |
Why?
|
HLA-B Antigens | 2 | 2012 | 353 | 0.620 |
Why?
|
Killer Cells, Natural | 25 | 2001 | 2133 | 0.610 |
Why?
|
T-Lymphocytes, Helper-Inducer | 23 | 2018 | 986 | 0.610 |
Why?
|
Epitopes, B-Lymphocyte | 4 | 2016 | 87 | 0.610 |
Why?
|
Genes | 19 | 1993 | 1893 | 0.590 |
Why?
|
Variola virus | 3 | 2007 | 11 | 0.590 |
Why?
|
Viral Proteins | 10 | 2021 | 1900 | 0.590 |
Why?
|
Influenza A Virus, H1N1 Subtype | 3 | 2017 | 459 | 0.580 |
Why?
|
Cytotoxicity, Immunologic | 36 | 2013 | 1369 | 0.580 |
Why?
|
Clone Cells | 61 | 1993 | 1692 | 0.570 |
Why?
|
Neprilysin | 11 | 1995 | 439 | 0.570 |
Why?
|
Binding Sites | 35 | 2011 | 6114 | 0.570 |
Why?
|
Retroviridae Proteins | 6 | 2001 | 98 | 0.560 |
Why?
|
Transfection | 32 | 2013 | 5892 | 0.550 |
Why?
|
Macromolecular Substances | 33 | 2003 | 1454 | 0.540 |
Why?
|
Sequence Analysis, Protein | 5 | 2013 | 258 | 0.520 |
Why?
|
Mice, Knockout | 21 | 2022 | 14557 | 0.510 |
Why?
|
Receptors, Fc | 9 | 1992 | 541 | 0.510 |
Why?
|
Interferon-gamma | 12 | 2021 | 3206 | 0.510 |
Why?
|
HLA-D Antigens | 7 | 2013 | 134 | 0.500 |
Why?
|
GTPase-Activating Proteins | 1 | 2018 | 498 | 0.500 |
Why?
|
Orthomyxoviridae Infections | 4 | 2017 | 248 | 0.490 |
Why?
|
Growth Substances | 4 | 2005 | 784 | 0.490 |
Why?
|
Vaccinia virus | 4 | 2009 | 349 | 0.490 |
Why?
|
Optical Tweezers | 4 | 2023 | 79 | 0.480 |
Why?
|
Mice, Inbred C57BL | 31 | 2018 | 21827 | 0.480 |
Why?
|
Immunoglobulin Fab Fragments | 4 | 2001 | 482 | 0.480 |
Why?
|
Smallpox Vaccine | 3 | 2009 | 80 | 0.470 |
Why?
|
Sequence Alignment | 17 | 2015 | 2256 | 0.470 |
Why?
|
Carrier Proteins | 14 | 2003 | 5021 | 0.460 |
Why?
|
Computational Biology | 11 | 2017 | 3521 | 0.460 |
Why?
|
Tyrosine | 12 | 2001 | 1461 | 0.460 |
Why?
|
Sequence Homology, Amino Acid | 13 | 2015 | 2839 | 0.460 |
Why?
|
Cell Line | 51 | 2017 | 15997 | 0.450 |
Why?
|
Gene Expression Regulation | 13 | 2016 | 12072 | 0.450 |
Why?
|
Software | 11 | 2015 | 4443 | 0.440 |
Why?
|
Conserved Sequence | 9 | 2018 | 1202 | 0.440 |
Why?
|
Phosphoglycerate Kinase | 1 | 2012 | 68 | 0.440 |
Why?
|
Antibodies, Neutralizing | 8 | 2023 | 1978 | 0.430 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2012 | 79 | 0.430 |
Why?
|
Humans | 349 | 2024 | 744343 | 0.430 |
Why?
|
beta Karyopherins | 1 | 2012 | 47 | 0.430 |
Why?
|
Membrane Fusion | 2 | 2013 | 273 | 0.430 |
Why?
|
Vaccines | 5 | 2023 | 822 | 0.430 |
Why?
|
Cyclophilin A | 1 | 2012 | 57 | 0.430 |
Why?
|
CD4-Positive T-Lymphocytes | 13 | 2022 | 4386 | 0.420 |
Why?
|
Crystallography, X-Ray | 12 | 2020 | 2011 | 0.420 |
Why?
|
Orthomyxoviridae | 4 | 2015 | 156 | 0.420 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2013 | 265 | 0.420 |
Why?
|
Base Sequence | 43 | 2012 | 12797 | 0.410 |
Why?
|
Dideoxynucleosides | 1 | 2012 | 122 | 0.410 |
Why?
|
Virus Internalization | 2 | 2013 | 501 | 0.410 |
Why?
|
Mass Spectrometry | 7 | 2019 | 2203 | 0.410 |
Why?
|
Databases, Protein | 5 | 2017 | 383 | 0.400 |
Why?
|
Lymphokines | 9 | 2001 | 949 | 0.400 |
Why?
|
Mice, Transgenic | 20 | 2023 | 9734 | 0.390 |
Why?
|
Membrane Proteins | 13 | 2018 | 7880 | 0.390 |
Why?
|
Protein Subunits | 4 | 2015 | 959 | 0.380 |
Why?
|
Vesicular stomatitis Indiana virus | 6 | 2003 | 94 | 0.380 |
Why?
|
Flow Cytometry | 24 | 2019 | 5974 | 0.380 |
Why?
|
Leukemia, Lymphoid | 13 | 1988 | 315 | 0.370 |
Why?
|
Neutralization Tests | 10 | 2018 | 758 | 0.360 |
Why?
|
Mutagenesis, Site-Directed | 13 | 2013 | 1723 | 0.360 |
Why?
|
Antibody Formation | 17 | 2018 | 1402 | 0.360 |
Why?
|
Adaptor Proteins, Signal Transducing | 8 | 2009 | 2916 | 0.350 |
Why?
|
Antigen-Presenting Cells | 9 | 2017 | 973 | 0.350 |
Why?
|
Semaphorins | 3 | 2018 | 101 | 0.350 |
Why?
|
Magnetic Resonance Spectroscopy | 10 | 2024 | 3760 | 0.340 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 7 | 1992 | 318 | 0.340 |
Why?
|
Molecular Weight | 30 | 1999 | 2255 | 0.340 |
Why?
|
Lung | 5 | 2017 | 9856 | 0.340 |
Why?
|
Clonal Deletion | 3 | 2004 | 79 | 0.330 |
Why?
|
Genes, MHC Class II | 6 | 2013 | 457 | 0.330 |
Why?
|
Immunologic Memory | 6 | 2017 | 1348 | 0.330 |
Why?
|
Autoimmune Diseases | 7 | 2018 | 2133 | 0.320 |
Why?
|
Human papillomavirus 16 | 1 | 2010 | 262 | 0.320 |
Why?
|
Keratinocytes | 1 | 2012 | 798 | 0.320 |
Why?
|
Dimerization | 12 | 2005 | 893 | 0.320 |
Why?
|
Recombinant Proteins | 19 | 2005 | 6622 | 0.310 |
Why?
|
Structure-Activity Relationship | 12 | 2019 | 3129 | 0.300 |
Why?
|
Surface Plasmon Resonance | 6 | 2008 | 274 | 0.300 |
Why?
|
Glycosylation | 12 | 2005 | 1126 | 0.300 |
Why?
|
Cloning, Molecular | 18 | 1998 | 4320 | 0.300 |
Why?
|
Cytoplasm | 9 | 2014 | 1539 | 0.290 |
Why?
|
Viral Matrix Proteins | 1 | 2008 | 186 | 0.290 |
Why?
|
Calcium | 19 | 2015 | 5756 | 0.290 |
Why?
|
beta 2-Microglobulin | 6 | 2004 | 315 | 0.290 |
Why?
|
Protein Array Analysis | 1 | 2009 | 411 | 0.290 |
Why?
|
Receptors, IgG | 7 | 1996 | 582 | 0.280 |
Why?
|
Oligopeptides | 4 | 2001 | 1189 | 0.280 |
Why?
|
Amino Acid Motifs | 7 | 2014 | 936 | 0.280 |
Why?
|
Epitope Mapping | 6 | 2015 | 311 | 0.270 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2006 | 473 | 0.270 |
Why?
|
Recombinant Fusion Proteins | 14 | 2004 | 3772 | 0.270 |
Why?
|
Immunologic Deficiency Syndromes | 13 | 1985 | 547 | 0.260 |
Why?
|
N-Acetylneuraminic Acid | 2 | 2002 | 177 | 0.260 |
Why?
|
DNA-Binding Proteins | 13 | 2019 | 9648 | 0.250 |
Why?
|
Simian immunodeficiency virus | 3 | 2013 | 846 | 0.250 |
Why?
|
Smallpox | 1 | 2005 | 45 | 0.250 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2004 | 71 | 0.250 |
Why?
|
Neoplasms | 6 | 2023 | 21683 | 0.250 |
Why?
|
Proteins | 11 | 2011 | 6103 | 0.250 |
Why?
|
Nerve Tissue Proteins | 3 | 2018 | 4462 | 0.240 |
Why?
|
Autoimmunity | 1 | 2012 | 1349 | 0.240 |
Why?
|
Allergy and Immunology | 2 | 2019 | 169 | 0.240 |
Why?
|
Dendritic Cells | 4 | 2011 | 2725 | 0.230 |
Why?
|
HIV Antigens | 3 | 2016 | 347 | 0.230 |
Why?
|
Rosette Formation | 15 | 2001 | 153 | 0.230 |
Why?
|
Database Management Systems | 1 | 2005 | 270 | 0.230 |
Why?
|
Cell Separation | 21 | 2013 | 1751 | 0.230 |
Why?
|
Liposomes | 2 | 2018 | 759 | 0.220 |
Why?
|
DNA | 26 | 2005 | 7301 | 0.220 |
Why?
|
Immunity, Cellular | 10 | 2009 | 1607 | 0.220 |
Why?
|
Exons | 9 | 2000 | 2437 | 0.220 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2001 | 97 | 0.220 |
Why?
|
Jurkat Cells | 6 | 2014 | 743 | 0.220 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 2002 | 91 | 0.220 |
Why?
|
Receptors, IgE | 7 | 1996 | 389 | 0.220 |
Why?
|
Immunotherapy | 3 | 2015 | 4445 | 0.210 |
Why?
|
Electron Spin Resonance Spectroscopy | 3 | 2013 | 165 | 0.210 |
Why?
|
Viral Fusion Proteins | 2 | 2004 | 95 | 0.210 |
Why?
|
Membrane Lipids | 4 | 2016 | 248 | 0.210 |
Why?
|
Models, Immunological | 4 | 2015 | 527 | 0.210 |
Why?
|
Cancer Vaccines | 2 | 2023 | 1023 | 0.210 |
Why?
|
Cytokines | 8 | 2007 | 7322 | 0.210 |
Why?
|
Cell Movement | 2 | 2018 | 5217 | 0.210 |
Why?
|
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2001 | 33 | 0.210 |
Why?
|
Antibodies, Viral | 5 | 2015 | 3176 | 0.210 |
Why?
|
T-Lymphocytes, Regulatory | 31 | 1985 | 2988 | 0.210 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 2001 | 76 | 0.200 |
Why?
|
Immunologic Surveillance | 1 | 2002 | 93 | 0.200 |
Why?
|
Lymphocyte Culture Test, Mixed | 13 | 2003 | 517 | 0.200 |
Why?
|
Sheep | 10 | 2010 | 1437 | 0.200 |
Why?
|
Amino Acids | 3 | 2024 | 1736 | 0.200 |
Why?
|
Integrins | 2 | 2018 | 846 | 0.200 |
Why?
|
Morpholines | 1 | 2005 | 571 | 0.200 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2018 | 2915 | 0.200 |
Why?
|
Cricetinae | 13 | 2004 | 2472 | 0.200 |
Why?
|
Organ Culture Techniques | 4 | 2010 | 813 | 0.190 |
Why?
|
Membrane Microdomains | 2 | 2002 | 203 | 0.190 |
Why?
|
Receptors, Virus | 3 | 1989 | 648 | 0.190 |
Why?
|
Lysine | 2 | 2005 | 1007 | 0.190 |
Why?
|
GTP-Binding Proteins | 2 | 1998 | 970 | 0.190 |
Why?
|
Protein-Tyrosine Kinases | 9 | 2023 | 2455 | 0.190 |
Why?
|
Immunoglobulins | 9 | 2016 | 881 | 0.190 |
Why?
|
Phosphorylation | 13 | 2014 | 8436 | 0.190 |
Why?
|
Picornaviridae Infections | 1 | 2021 | 88 | 0.190 |
Why?
|
Transcription, Genetic | 15 | 2002 | 7722 | 0.180 |
Why?
|
DNA, Complementary | 5 | 2013 | 2050 | 0.180 |
Why?
|
Vaccination | 3 | 2023 | 3278 | 0.180 |
Why?
|
Rhinovirus | 1 | 2021 | 187 | 0.180 |
Why?
|
Nucleoproteins | 3 | 2010 | 115 | 0.180 |
Why?
|
Melanoma-Specific Antigens | 1 | 2019 | 80 | 0.180 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2000 | 1285 | 0.180 |
Why?
|
Antibodies, Bispecific | 1 | 2022 | 164 | 0.180 |
Why?
|
Oligodeoxyribonucleotides | 8 | 1993 | 708 | 0.180 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 11 | 2005 | 1801 | 0.180 |
Why?
|
Immune System | 2 | 2007 | 805 | 0.180 |
Why?
|
Mitogens | 4 | 1998 | 232 | 0.180 |
Why?
|
Protein Structure, Quaternary | 3 | 2010 | 436 | 0.180 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2003 | 560 | 0.170 |
Why?
|
Cell Division | 16 | 2002 | 4568 | 0.170 |
Why?
|
Protein Stability | 1 | 2021 | 557 | 0.170 |
Why?
|
Solubility | 13 | 2002 | 1085 | 0.170 |
Why?
|
Baculoviridae | 3 | 2006 | 118 | 0.170 |
Why?
|
Peptide Library | 4 | 2019 | 349 | 0.170 |
Why?
|
HIV | 4 | 2001 | 1604 | 0.170 |
Why?
|
Antibody Specificity | 14 | 2004 | 1095 | 0.170 |
Why?
|
Disulfides | 5 | 2014 | 457 | 0.170 |
Why?
|
Mice, Inbred BALB C | 12 | 2018 | 6386 | 0.170 |
Why?
|
Proto-Oncogene Proteins | 5 | 2005 | 4554 | 0.170 |
Why?
|
Kinetics | 14 | 2001 | 6473 | 0.170 |
Why?
|
User-Computer Interface | 2 | 2008 | 1431 | 0.170 |
Why?
|
Escherichia coli | 5 | 2024 | 4217 | 0.170 |
Why?
|
Plasma Cells | 4 | 2016 | 591 | 0.170 |
Why?
|
Antibodies | 16 | 1989 | 2460 | 0.160 |
Why?
|
Lymphocyte Cooperation | 12 | 1987 | 112 | 0.160 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 9438 | 0.160 |
Why?
|
Cytoskeleton | 3 | 2018 | 1185 | 0.160 |
Why?
|
Cells, Cultured | 20 | 2015 | 19229 | 0.160 |
Why?
|
Quinazolines | 1 | 2005 | 1356 | 0.160 |
Why?
|
Proteome | 2 | 2010 | 1799 | 0.160 |
Why?
|
Fluoresceins | 4 | 1992 | 235 | 0.160 |
Why?
|
Blotting, Western | 6 | 2006 | 5179 | 0.150 |
Why?
|
Polymerase Chain Reaction | 14 | 2010 | 6171 | 0.150 |
Why?
|
Biological Evolution | 2 | 1994 | 1076 | 0.150 |
Why?
|
CHO Cells | 10 | 2004 | 1406 | 0.150 |
Why?
|
Monocytes | 9 | 1999 | 2596 | 0.150 |
Why?
|
Apoptosis | 7 | 2003 | 9727 | 0.150 |
Why?
|
Integrin alpha Chains | 1 | 2017 | 97 | 0.150 |
Why?
|
Binding, Competitive | 12 | 2002 | 1157 | 0.150 |
Why?
|
Chromosome Mapping | 7 | 1993 | 4740 | 0.150 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2021 | 474 | 0.150 |
Why?
|
Immunogenetics | 2 | 2007 | 67 | 0.150 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 494 | 0.150 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2018 | 241 | 0.150 |
Why?
|
Immune Tolerance | 8 | 1993 | 2258 | 0.140 |
Why?
|
Point Mutation | 6 | 2001 | 1623 | 0.140 |
Why?
|
Th1 Cells | 1 | 2002 | 1057 | 0.140 |
Why?
|
Th2 Cells | 1 | 2002 | 1061 | 0.140 |
Why?
|
Transduction, Genetic | 3 | 2010 | 913 | 0.140 |
Why?
|
Cross-Linking Reagents | 6 | 2005 | 694 | 0.140 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2021 | 388 | 0.140 |
Why?
|
Immunoglobulin Variable Region | 3 | 1987 | 421 | 0.140 |
Why?
|
HIV Seropositivity | 1 | 2022 | 971 | 0.140 |
Why?
|
Alternative Splicing | 3 | 2001 | 1117 | 0.140 |
Why?
|
Nucleocapsid Proteins | 2 | 2007 | 77 | 0.140 |
Why?
|
Receptors, Interleukin-2 | 12 | 1989 | 573 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2011 | 3870 | 0.130 |
Why?
|
Polymorphism, Genetic | 4 | 2003 | 4328 | 0.130 |
Why?
|
RNA, Messenger | 13 | 2012 | 13033 | 0.130 |
Why?
|
Transcriptional Activation | 3 | 1997 | 1783 | 0.130 |
Why?
|
Immunoprecipitation | 2 | 2010 | 905 | 0.130 |
Why?
|
Sequence Homology, Nucleic Acid | 7 | 1992 | 1085 | 0.130 |
Why?
|
Ion Channels | 4 | 1988 | 1056 | 0.130 |
Why?
|
Restriction Mapping | 8 | 1992 | 878 | 0.130 |
Why?
|
Isoantigens | 6 | 2007 | 567 | 0.130 |
Why?
|
Hematopoietic System | 1 | 1995 | 109 | 0.130 |
Why?
|
Genome | 1 | 2003 | 1808 | 0.130 |
Why?
|
Immunoglobulin Class Switching | 1 | 2016 | 291 | 0.130 |
Why?
|
Cell Lineage | 2 | 2002 | 2504 | 0.120 |
Why?
|
Algorithms | 9 | 2013 | 13881 | 0.120 |
Why?
|
Binding Sites, Antibody | 5 | 2023 | 349 | 0.120 |
Why?
|
Gene Expression | 8 | 2012 | 7799 | 0.120 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 2 | 1991 | 222 | 0.120 |
Why?
|
Invertebrates | 1 | 1994 | 50 | 0.120 |
Why?
|
Receptors, Antigen | 2 | 1984 | 53 | 0.120 |
Why?
|
Cysteine Endopeptidases | 1 | 1997 | 563 | 0.120 |
Why?
|
Polysaccharides | 4 | 2018 | 1053 | 0.120 |
Why?
|
Cell Transformation, Viral | 5 | 1984 | 565 | 0.120 |
Why?
|
Enterotoxins | 2 | 1993 | 368 | 0.120 |
Why?
|
COS Cells | 3 | 2009 | 1161 | 0.120 |
Why?
|
Recombination, Genetic | 2 | 2016 | 1586 | 0.120 |
Why?
|
Viral Envelope Proteins | 2 | 2007 | 635 | 0.120 |
Why?
|
Spleen | 9 | 2001 | 2362 | 0.120 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1038 | 0.120 |
Why?
|
Rabbits | 7 | 2007 | 4894 | 0.120 |
Why?
|
Cell Hypoxia | 1 | 2016 | 675 | 0.120 |
Why?
|
Caspases | 1 | 1997 | 928 | 0.120 |
Why?
|
Germinal Center | 1 | 2016 | 377 | 0.120 |
Why?
|
Mutation | 15 | 2019 | 29786 | 0.120 |
Why?
|
Static Electricity | 3 | 2005 | 267 | 0.120 |
Why?
|
Microscopy, Electron | 3 | 2006 | 2645 | 0.120 |
Why?
|
Phosphotyrosine | 5 | 1998 | 457 | 0.120 |
Why?
|
Databases, Genetic | 2 | 2014 | 1783 | 0.120 |
Why?
|
Phenotype | 26 | 2007 | 16365 | 0.120 |
Why?
|
Alleles | 6 | 2019 | 6933 | 0.120 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 2 | 2006 | 5 | 0.120 |
Why?
|
Protein Processing, Post-Translational | 1 | 2001 | 1990 | 0.110 |
Why?
|
Trypsin | 4 | 2005 | 511 | 0.110 |
Why?
|
Circular Dichroism | 5 | 2002 | 354 | 0.110 |
Why?
|
Substance P | 2 | 1991 | 335 | 0.110 |
Why?
|
Transcytosis | 1 | 2013 | 44 | 0.110 |
Why?
|
Glycopeptides | 4 | 2002 | 224 | 0.110 |
Why?
|
Blotting, Northern | 6 | 1994 | 1581 | 0.110 |
Why?
|
Crystallization | 4 | 2009 | 524 | 0.110 |
Why?
|
K562 Cells | 2 | 2013 | 634 | 0.110 |
Why?
|
Molecular Conformation | 3 | 2009 | 563 | 0.110 |
Why?
|
Stochastic Processes | 1 | 2013 | 344 | 0.110 |
Why?
|
Protein Folding | 3 | 2017 | 843 | 0.110 |
Why?
|
Promoter Regions, Genetic | 5 | 1998 | 5867 | 0.110 |
Why?
|
Data Mining | 2 | 2015 | 537 | 0.110 |
Why?
|
Erythrocytes | 5 | 2001 | 2455 | 0.110 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 2 | 1991 | 378 | 0.110 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 3 | 2005 | 370 | 0.100 |
Why?
|
Bombesin | 1 | 1991 | 34 | 0.100 |
Why?
|
Concanavalin A | 9 | 1986 | 191 | 0.100 |
Why?
|
Sialyltransferases | 2 | 2002 | 75 | 0.100 |
Why?
|
History, 20th Century | 3 | 2019 | 2740 | 0.100 |
Why?
|
Sequence Analysis, DNA | 4 | 2012 | 4803 | 0.100 |
Why?
|
Lymphocytes | 5 | 1999 | 2617 | 0.100 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 464 | 0.100 |
Why?
|
Genes, MHC Class I | 1 | 2012 | 258 | 0.100 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 3 | 2002 | 279 | 0.100 |
Why?
|
Feedback, Physiological | 1 | 2014 | 479 | 0.100 |
Why?
|
Medical Oncology | 1 | 2023 | 2265 | 0.100 |
Why?
|
Amino Acid Substitution | 3 | 2007 | 1791 | 0.100 |
Why?
|
Proline | 4 | 2003 | 458 | 0.100 |
Why?
|
HIV Infections | 5 | 2023 | 16718 | 0.100 |
Why?
|
Hydrogen Bonding | 3 | 2001 | 293 | 0.100 |
Why?
|
Precipitin Tests | 3 | 2003 | 829 | 0.100 |
Why?
|
RNA Processing, Post-Transcriptional | 2 | 1991 | 436 | 0.100 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 3 | 2000 | 67 | 0.100 |
Why?
|
Fetus | 3 | 1993 | 1880 | 0.100 |
Why?
|
Interleukin-12 | 3 | 2001 | 579 | 0.100 |
Why?
|
Enkephalin, Methionine | 1 | 1990 | 26 | 0.100 |
Why?
|
Virion | 1 | 2013 | 433 | 0.100 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 976 | 0.100 |
Why?
|
Bivalvia | 1 | 1990 | 53 | 0.100 |
Why?
|
Fluorescent Antibody Technique | 12 | 2009 | 2505 | 0.100 |
Why?
|
Hemocytes | 1 | 1990 | 41 | 0.100 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13102 | 0.090 |
Why?
|
Aluminum Compounds | 1 | 1990 | 51 | 0.090 |
Why?
|
DNA Primers | 4 | 2012 | 2892 | 0.090 |
Why?
|
Genetic Variation | 6 | 2014 | 6544 | 0.090 |
Why?
|
Chromatography, Gel | 3 | 2001 | 668 | 0.090 |
Why?
|
Chemotaxis | 1 | 2013 | 607 | 0.090 |
Why?
|
Cross Protection | 1 | 2010 | 24 | 0.090 |
Why?
|
Immunity, Innate | 4 | 1994 | 2958 | 0.090 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2010 | 123 | 0.090 |
Why?
|
Cell Adhesion Molecules | 2 | 1999 | 1602 | 0.090 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 1993 | 658 | 0.090 |
Why?
|
Bone Marrow Transplantation | 4 | 2001 | 2765 | 0.090 |
Why?
|
Female | 54 | 2021 | 380194 | 0.090 |
Why?
|
Antigen-Antibody Reactions | 8 | 1997 | 363 | 0.090 |
Why?
|
Lymphocyte Count | 2 | 2003 | 793 | 0.090 |
Why?
|
Models, Biological | 5 | 2015 | 9583 | 0.090 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 2007 | 0.090 |
Why?
|
Polyglycolic Acid | 1 | 2011 | 407 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2018 | 1270 | 0.090 |
Why?
|
Immunoglobulin A | 1 | 2013 | 992 | 0.090 |
Why?
|
Agammaglobulinemia | 5 | 1984 | 167 | 0.090 |
Why?
|
Hybrid Cells | 6 | 1989 | 441 | 0.090 |
Why?
|
Chemokines | 1 | 2013 | 970 | 0.090 |
Why?
|
Carcinoma, Small Cell | 1 | 1991 | 420 | 0.090 |
Why?
|
Mutagenesis | 3 | 2017 | 1266 | 0.090 |
Why?
|
Cell Fusion | 2 | 1988 | 297 | 0.090 |
Why?
|
Receptors, CXCR4 | 1 | 2014 | 726 | 0.080 |
Why?
|
Lymphocyte Transfusion | 1 | 2010 | 236 | 0.080 |
Why?
|
Autoantibodies | 4 | 2013 | 2035 | 0.080 |
Why?
|
Immunoglobulin G | 13 | 2023 | 4560 | 0.080 |
Why?
|
Receptors, CCR | 1 | 2008 | 38 | 0.080 |
Why?
|
Viral Structural Proteins | 1 | 2009 | 103 | 0.080 |
Why?
|
Immunization | 3 | 2013 | 1256 | 0.080 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3505 | 0.080 |
Why?
|
Enzyme Activation | 5 | 2000 | 3701 | 0.080 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2013 | 570 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-fyn | 3 | 2008 | 116 | 0.080 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2187 | 0.080 |
Why?
|
Oncogene Proteins, Viral | 1 | 2010 | 362 | 0.080 |
Why?
|
Rats | 9 | 2002 | 24260 | 0.080 |
Why?
|
Receptors, Cell Surface | 3 | 2003 | 2866 | 0.080 |
Why?
|
Mitochondria | 1 | 2001 | 3520 | 0.080 |
Why?
|
Immunoglobulin Constant Regions | 2 | 1985 | 59 | 0.080 |
Why?
|
Graft vs Host Reaction | 4 | 1982 | 104 | 0.080 |
Why?
|
Influenza Vaccines | 1 | 2015 | 738 | 0.080 |
Why?
|
Virulence Factors | 1 | 2011 | 509 | 0.080 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1989 | 323 | 0.080 |
Why?
|
Papillomaviridae | 1 | 2014 | 1119 | 0.080 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2009 | 279 | 0.080 |
Why?
|
Papillomavirus Vaccines | 1 | 2014 | 491 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1970 | 0.080 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 222 | 0.080 |
Why?
|
Mice, Inbred Strains | 4 | 1993 | 1827 | 0.080 |
Why?
|
Guinea Pigs | 2 | 2006 | 1386 | 0.080 |
Why?
|
Internet | 4 | 2008 | 3064 | 0.080 |
Why?
|
Transcription Factors | 4 | 2003 | 12208 | 0.080 |
Why?
|
Capsid | 2 | 1998 | 436 | 0.080 |
Why?
|
Lectins, C-Type | 2 | 2008 | 588 | 0.070 |
Why?
|
Antigens, Bacterial | 2 | 1992 | 1171 | 0.070 |
Why?
|
Tumor Cells, Cultured | 5 | 2001 | 6314 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 1998 | 3462 | 0.070 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2007 | 90 | 0.070 |
Why?
|
Viral Core Proteins | 1 | 2007 | 162 | 0.070 |
Why?
|
Chromatography, Affinity | 4 | 1996 | 549 | 0.070 |
Why?
|
Proto-Oncogenes | 1 | 1987 | 321 | 0.070 |
Why?
|
Molecular Structure | 4 | 2003 | 1899 | 0.070 |
Why?
|
Pokeweed Mitogens | 7 | 1985 | 38 | 0.070 |
Why?
|
RNA Splicing | 1 | 1991 | 907 | 0.070 |
Why?
|
Bronchi | 1 | 2010 | 840 | 0.070 |
Why?
|
Phosphatidylinositols | 4 | 1991 | 291 | 0.070 |
Why?
|
DNA, Neoplasm | 2 | 1989 | 1758 | 0.070 |
Why?
|
Epithelial Cells | 3 | 2015 | 3690 | 0.070 |
Why?
|
Phytohemagglutinins | 7 | 1996 | 170 | 0.070 |
Why?
|
Phospholipase C gamma | 1 | 2006 | 128 | 0.070 |
Why?
|
Homosexuality | 2 | 1984 | 262 | 0.070 |
Why?
|
Fluorescein | 3 | 1992 | 171 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1376 | 0.070 |
Why?
|
Chromosomes, Human, 13-15 | 1 | 1985 | 52 | 0.070 |
Why?
|
Type C Phospholipases | 2 | 2000 | 292 | 0.070 |
Why?
|
Bacteriophages | 2 | 2004 | 356 | 0.070 |
Why?
|
Thermodynamics | 3 | 2002 | 596 | 0.070 |
Why?
|
Lactic Acid | 1 | 2011 | 1133 | 0.070 |
Why?
|
Plasmids | 4 | 1992 | 2307 | 0.070 |
Why?
|
Artificial Intelligence | 2 | 2011 | 2214 | 0.070 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 1984 | 80 | 0.060 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 689 | 0.060 |
Why?
|
Genetic Linkage | 4 | 1992 | 2421 | 0.060 |
Why?
|
Neoplasm Proteins | 2 | 2007 | 3703 | 0.060 |
Why?
|
Nucleic Acid Hybridization | 4 | 1989 | 1375 | 0.060 |
Why?
|
Immunoglobulin Allotypes | 1 | 1984 | 56 | 0.060 |
Why?
|
Calcium Channels | 1 | 1989 | 622 | 0.060 |
Why?
|
Tetradecanoylphorbol Acetate | 6 | 1991 | 821 | 0.060 |
Why?
|
Probability | 1 | 2010 | 2505 | 0.060 |
Why?
|
Down-Regulation | 4 | 2006 | 3002 | 0.060 |
Why?
|
Lymphatic Diseases | 2 | 1984 | 324 | 0.060 |
Why?
|
Classification | 3 | 1979 | 129 | 0.060 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2003 | 407 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2005 | 119 | 0.060 |
Why?
|
Vaccinia | 1 | 2005 | 76 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5221 | 0.060 |
Why?
|
src Homology Domains | 3 | 2002 | 364 | 0.060 |
Why?
|
Aspartate Carbamoyltransferase | 1 | 2004 | 22 | 0.060 |
Why?
|
Ultracentrifugation | 2 | 2001 | 182 | 0.060 |
Why?
|
Blotting, Southern | 3 | 1989 | 803 | 0.060 |
Why?
|
Protein Biosynthesis | 5 | 1991 | 2126 | 0.060 |
Why?
|
Umbilical Cord | 1 | 1985 | 180 | 0.060 |
Why?
|
Lymphoma | 5 | 1989 | 1877 | 0.060 |
Why?
|
Retroviridae | 1 | 2007 | 914 | 0.060 |
Why?
|
Lymph Nodes | 5 | 2002 | 3474 | 0.060 |
Why?
|
Octamer Transcription Factor-1 | 2 | 1994 | 32 | 0.060 |
Why?
|
Cell Line, Tumor | 4 | 2019 | 16689 | 0.060 |
Why?
|
Immune Sera | 2 | 1985 | 641 | 0.060 |
Why?
|
DNA, Viral | 2 | 2006 | 2225 | 0.060 |
Why?
|
Host Cell Factor C1 | 2 | 1994 | 31 | 0.060 |
Why?
|
Interphase | 2 | 2002 | 226 | 0.060 |
Why?
|
Vero Cells | 1 | 2005 | 485 | 0.060 |
Why?
|
Receptors, HIV | 3 | 1989 | 162 | 0.060 |
Why?
|
Oncogene Proteins | 1 | 2008 | 749 | 0.060 |
Why?
|
Gene Targeting | 1 | 2007 | 880 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2005 | 2557 | 0.060 |
Why?
|
Subcellular Fractions | 2 | 2002 | 547 | 0.060 |
Why?
|
Genes, Reporter | 2 | 2005 | 1547 | 0.060 |
Why?
|
Protein Engineering | 2 | 2005 | 540 | 0.060 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 2 | 1981 | 307 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 625 | 0.060 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4851 | 0.060 |
Why?
|
Crk-Associated Substrate Protein | 1 | 2003 | 41 | 0.060 |
Why?
|
Nanoparticles | 2 | 2015 | 1905 | 0.060 |
Why?
|
Leucine Zippers | 3 | 1999 | 117 | 0.060 |
Why?
|
Selection, Genetic | 2 | 2001 | 914 | 0.060 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2003 | 76 | 0.060 |
Why?
|
Influenza, Human | 2 | 2011 | 1479 | 0.060 |
Why?
|
Scattering, Radiation | 1 | 2005 | 498 | 0.060 |
Why?
|
DNA Mutational Analysis | 4 | 2005 | 4186 | 0.060 |
Why?
|
Genetic Vectors | 4 | 2009 | 3420 | 0.060 |
Why?
|
Viral Vaccines | 1 | 2009 | 636 | 0.060 |
Why?
|
Luciferases | 1 | 2005 | 733 | 0.060 |
Why?
|
Male | 38 | 2021 | 350118 | 0.060 |
Why?
|
Chromium | 1 | 2003 | 123 | 0.060 |
Why?
|
Consensus Sequence | 1 | 2003 | 377 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 697 | 0.060 |
Why?
|
Oligonucleotide Probes | 3 | 1992 | 427 | 0.060 |
Why?
|
Vaccines, Subunit | 1 | 2023 | 168 | 0.050 |
Why?
|
Immunity, Maternally-Acquired | 1 | 1983 | 118 | 0.050 |
Why?
|
Multiple Sclerosis | 9 | 1986 | 3079 | 0.050 |
Why?
|
HeLa Cells | 2 | 2009 | 3128 | 0.050 |
Why?
|
Ribonucleases | 2 | 1994 | 287 | 0.050 |
Why?
|
Isoelectric Focusing | 2 | 1996 | 181 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2005 | 10943 | 0.050 |
Why?
|
Hematopoiesis | 3 | 1992 | 2072 | 0.050 |
Why?
|
Two-Hybrid System Techniques | 1 | 2003 | 464 | 0.050 |
Why?
|
Neutrophils | 2 | 1991 | 3719 | 0.050 |
Why?
|
Peptide Hydrolases | 1 | 2005 | 634 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2727 | 0.050 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 113 | 0.050 |
Why?
|
Chromatography | 1 | 2001 | 206 | 0.050 |
Why?
|
Herpesviridae Infections | 1 | 1983 | 277 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 1988 | 2232 | 0.050 |
Why?
|
Calorimetry | 1 | 2001 | 126 | 0.050 |
Why?
|
Protein Interaction Mapping | 2 | 2002 | 627 | 0.050 |
Why?
|
Surface Properties | 1 | 2004 | 1184 | 0.050 |
Why?
|
Sequence Deletion | 1 | 2006 | 1526 | 0.050 |
Why?
|
Plant Proteins | 1 | 1984 | 364 | 0.050 |
Why?
|
Stem Cells | 2 | 1999 | 3567 | 0.050 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2001 | 93 | 0.050 |
Why?
|
Melanoma | 2 | 2019 | 5510 | 0.050 |
Why?
|
Evolution, Molecular | 1 | 2010 | 1940 | 0.050 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 1982 | 97 | 0.050 |
Why?
|
Protein Renaturation | 1 | 2000 | 10 | 0.050 |
Why?
|
Molecular Mimicry | 1 | 2022 | 201 | 0.050 |
Why?
|
Epidermal Growth Factor | 1 | 2004 | 708 | 0.050 |
Why?
|
CpG Islands | 1 | 2005 | 1172 | 0.050 |
Why?
|
Immunosorbent Techniques | 4 | 1989 | 184 | 0.050 |
Why?
|
Chemistry | 3 | 1986 | 352 | 0.050 |
Why?
|
Goats | 4 | 1981 | 171 | 0.050 |
Why?
|
Proteomics | 3 | 2014 | 3638 | 0.050 |
Why?
|
Receptors, Cytokine | 1 | 2001 | 261 | 0.050 |
Why?
|
Inhibitory Concentration 50 | 1 | 2001 | 459 | 0.050 |
Why?
|
Substrate Specificity | 3 | 2001 | 1801 | 0.050 |
Why?
|
Chemical Phenomena | 3 | 1986 | 518 | 0.050 |
Why?
|
Lymphopenia | 3 | 2001 | 285 | 0.050 |
Why?
|
Interleukin-4 | 4 | 1990 | 1147 | 0.050 |
Why?
|
Electron Transport Complex I | 1 | 2001 | 140 | 0.050 |
Why?
|
Protein Kinase C | 2 | 2000 | 1227 | 0.050 |
Why?
|
Protein Denaturation | 1 | 2000 | 237 | 0.050 |
Why?
|
Conalbumin | 1 | 1999 | 5 | 0.050 |
Why?
|
RNA | 6 | 1992 | 2749 | 0.050 |
Why?
|
Bone Marrow Cells | 3 | 1992 | 2513 | 0.050 |
Why?
|
Sequence Analysis | 2 | 1998 | 256 | 0.050 |
Why?
|
Dose-Response Relationship, Immunologic | 5 | 1989 | 370 | 0.050 |
Why?
|
Haplotypes | 1 | 2007 | 2779 | 0.050 |
Why?
|
Mice, Inbred AKR | 1 | 1999 | 107 | 0.050 |
Why?
|
Enterocytes | 1 | 2001 | 225 | 0.050 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2000 | 452 | 0.050 |
Why?
|
Lymphoid Tissue | 2 | 1995 | 455 | 0.050 |
Why?
|
Infectious Mononucleosis | 1 | 1980 | 131 | 0.050 |
Why?
|
Mice, Inbred CBA | 1 | 2000 | 448 | 0.050 |
Why?
|
Up-Regulation | 2 | 2007 | 4217 | 0.040 |
Why?
|
Computer Graphics | 2 | 1992 | 361 | 0.040 |
Why?
|
Gene Frequency | 1 | 2007 | 3588 | 0.040 |
Why?
|
Immunophenotyping | 2 | 2003 | 1880 | 0.040 |
Why?
|
Lymphocyte Depletion | 3 | 1997 | 608 | 0.040 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 1519 | 0.040 |
Why?
|
Virus Replication | 1 | 1988 | 2534 | 0.040 |
Why?
|
Superantigens | 1 | 1999 | 129 | 0.040 |
Why?
|
Antigens, Plant | 2 | 2013 | 86 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 2088 | 0.040 |
Why?
|
Virus Latency | 1 | 2022 | 358 | 0.040 |
Why?
|
Cytotoxicity Tests, Immunologic | 2 | 1992 | 329 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 571 | 0.040 |
Why?
|
Drug Design | 1 | 2005 | 1076 | 0.040 |
Why?
|
Immunologic Capping | 1 | 1998 | 31 | 0.040 |
Why?
|
Inclusion Bodies | 1 | 2000 | 279 | 0.040 |
Why?
|
Antigen-Antibody Complex | 3 | 1986 | 517 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2005 | 824 | 0.040 |
Why?
|
Antibody-Producing Cells | 3 | 1984 | 143 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2010 | 3023 | 0.040 |
Why?
|
Papain | 2 | 1989 | 64 | 0.040 |
Why?
|
Protein Transport | 1 | 2005 | 1988 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2005 | 1341 | 0.040 |
Why?
|
Peptide Mapping | 2 | 1990 | 263 | 0.040 |
Why?
|
Gene Deletion | 3 | 2001 | 2751 | 0.040 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2005 | 1338 | 0.040 |
Why?
|
Phosphoproteins | 2 | 2003 | 2440 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2001 | 694 | 0.040 |
Why?
|
Light | 1 | 2005 | 1374 | 0.040 |
Why?
|
Gene Library | 2 | 1992 | 1074 | 0.040 |
Why?
|
Immune System Diseases | 3 | 1987 | 262 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 489 | 0.040 |
Why?
|
Immunoglobulin E | 3 | 1992 | 1463 | 0.040 |
Why?
|
Mammals | 1 | 2024 | 1143 | 0.040 |
Why?
|
Nitric Oxide Synthase | 1 | 2001 | 916 | 0.040 |
Why?
|
Transgenes | 1 | 2001 | 1009 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2007 | 1903 | 0.040 |
Why?
|
Immunoblotting | 1 | 2001 | 1682 | 0.040 |
Why?
|
Cattle | 3 | 2002 | 3922 | 0.040 |
Why?
|
Hybridomas | 2 | 2005 | 452 | 0.040 |
Why?
|
Caspase 6 | 1 | 1997 | 15 | 0.040 |
Why?
|
Liver | 1 | 1993 | 7474 | 0.040 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 1997 | 68 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2007 | 2564 | 0.040 |
Why?
|
Caspase 7 | 1 | 1997 | 56 | 0.040 |
Why?
|
Lipid Bilayers | 1 | 2019 | 381 | 0.040 |
Why?
|
Hexosaminidases | 1 | 1996 | 54 | 0.040 |
Why?
|
Dogs | 1 | 2002 | 3912 | 0.040 |
Why?
|
Enzyme Precursors | 1 | 1997 | 176 | 0.040 |
Why?
|
Models, Genetic | 2 | 2005 | 3494 | 0.040 |
Why?
|
Transcription Factor AP-1 | 1 | 1998 | 317 | 0.040 |
Why?
|
Antilymphocyte Serum | 5 | 1983 | 492 | 0.040 |
Why?
|
Half-Life | 1 | 2018 | 661 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1997 | 190 | 0.040 |
Why?
|
Genotype | 2 | 2012 | 12951 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1676 | 0.040 |
Why?
|
Gene Products, tax | 2 | 1998 | 51 | 0.040 |
Why?
|
Allergens | 1 | 1984 | 1320 | 0.040 |
Why?
|
Oligosaccharides | 2 | 1995 | 414 | 0.030 |
Why?
|
Phosphopeptides | 1 | 1997 | 241 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2012 | 19905 | 0.030 |
Why?
|
Cricetulus | 2 | 1988 | 816 | 0.030 |
Why?
|
Cell Cycle | 4 | 1993 | 2967 | 0.030 |
Why?
|
Macaca mulatta | 3 | 2013 | 2375 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2000 | 1097 | 0.030 |
Why?
|
Cross Reactions | 3 | 2009 | 841 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1660 | 0.030 |
Why?
|
Immunoenzyme Techniques | 4 | 1995 | 1799 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2013 | 5181 | 0.030 |
Why?
|
Histones | 1 | 2006 | 2599 | 0.030 |
Why?
|
Cell Polarity | 1 | 1998 | 645 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2005 | 1861 | 0.030 |
Why?
|
Isoelectric Point | 2 | 1985 | 80 | 0.030 |
Why?
|
Leukocyte Count | 5 | 1999 | 1588 | 0.030 |
Why?
|
Databases as Topic | 1 | 2017 | 475 | 0.030 |
Why?
|
Cell Communication | 4 | 2003 | 1621 | 0.030 |
Why?
|
Graft Rejection | 3 | 2001 | 4397 | 0.030 |
Why?
|
Anisotropy | 1 | 2018 | 1265 | 0.030 |
Why?
|
Caspase 3 | 1 | 1997 | 758 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 1989 | 794 | 0.030 |
Why?
|
Lymphocytes, Null | 3 | 1983 | 13 | 0.030 |
Why?
|
Genetic Code | 2 | 1985 | 154 | 0.030 |
Why?
|
src-Family Kinases | 1 | 1997 | 551 | 0.030 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2015 | 157 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1998 | 2327 | 0.030 |
Why?
|
Dinitrobenzenes | 3 | 1983 | 37 | 0.030 |
Why?
|
Infant | 11 | 1985 | 35136 | 0.030 |
Why?
|
Membrane Potentials | 2 | 1989 | 1137 | 0.030 |
Why?
|
Adult | 33 | 2021 | 214055 | 0.030 |
Why?
|
Genes, Overlapping | 1 | 1993 | 36 | 0.030 |
Why?
|
Knowledge Bases | 1 | 2014 | 85 | 0.030 |
Why?
|
Time Factors | 5 | 2005 | 40075 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 6 | 1985 | 2104 | 0.030 |
Why?
|
Leukemia | 5 | 1985 | 1511 | 0.030 |
Why?
|
Self Tolerance | 1 | 1994 | 125 | 0.030 |
Why?
|
Administration, Rectal | 1 | 2013 | 73 | 0.030 |
Why?
|
Crystallography | 2 | 2009 | 111 | 0.030 |
Why?
|
NF-kappa B | 1 | 2002 | 2499 | 0.030 |
Why?
|
Herpesvirus 4, Human | 3 | 1983 | 1041 | 0.030 |
Why?
|
Pneumonia | 1 | 2005 | 2133 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2000 | 1526 | 0.030 |
Why?
|
Quality Control | 1 | 2015 | 841 | 0.030 |
Why?
|
Online Systems | 1 | 2013 | 184 | 0.030 |
Why?
|
Cycloheximide | 1 | 1992 | 347 | 0.030 |
Why?
|
Dactinomycin | 1 | 1992 | 318 | 0.030 |
Why?
|
Organ Specificity | 2 | 1995 | 2008 | 0.030 |
Why?
|
Electrochemistry | 1 | 1992 | 145 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2001 | 2132 | 0.030 |
Why?
|
Receptors, Bombesin | 1 | 1991 | 27 | 0.030 |
Why?
|
Oligonucleotides, Antisense | 1 | 1994 | 433 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3920 | 0.030 |
Why?
|
Vaccines, DNA | 1 | 2013 | 305 | 0.030 |
Why?
|
Receptors, Neurotransmitter | 1 | 1991 | 178 | 0.020 |
Why?
|
DNA Methylation | 1 | 2005 | 4286 | 0.020 |
Why?
|
Histamine Release | 1 | 1991 | 142 | 0.020 |
Why?
|
L-Selectin | 1 | 1991 | 213 | 0.020 |
Why?
|
Epithelium | 2 | 1988 | 1679 | 0.020 |
Why?
|
Dipeptides | 1 | 1993 | 409 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 1996 | 1000 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2011 | 11366 | 0.020 |
Why?
|
Phenylalanine | 1 | 1992 | 365 | 0.020 |
Why?
|
Adenosine Diphosphate Ribose | 1 | 1990 | 63 | 0.020 |
Why?
|
Immunization, Passive | 1 | 2013 | 623 | 0.020 |
Why?
|
Cyanogen Bromide | 1 | 1990 | 73 | 0.020 |
Why?
|
Macrophage-1 Antigen | 1 | 1991 | 290 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 1997 | 931 | 0.020 |
Why?
|
HLA-DR4 Antigen | 1 | 1990 | 28 | 0.020 |
Why?
|
Lectins | 2 | 1984 | 513 | 0.020 |
Why?
|
Sezary Syndrome | 2 | 1981 | 76 | 0.020 |
Why?
|
Virulence Factors, Bordetella | 1 | 1990 | 156 | 0.020 |
Why?
|
Pertussis Toxin | 1 | 1990 | 178 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 1992 | 964 | 0.020 |
Why?
|
Leukocytes | 1 | 1998 | 2043 | 0.020 |
Why?
|
Macrophages | 6 | 1999 | 5655 | 0.020 |
Why?
|
Basophils | 1 | 1992 | 389 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2006 | 10481 | 0.020 |
Why?
|
Receptors, Transferrin | 2 | 1989 | 296 | 0.020 |
Why?
|
Child, Preschool | 12 | 1985 | 41006 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2012 | 323 | 0.020 |
Why?
|
Cross-Priming | 1 | 2010 | 82 | 0.020 |
Why?
|
Hodgkin Disease | 3 | 1983 | 1415 | 0.020 |
Why?
|
Databases, Factual | 3 | 2015 | 7729 | 0.020 |
Why?
|
Genes, Viral | 1 | 1991 | 718 | 0.020 |
Why?
|
Fluorides | 1 | 1990 | 127 | 0.020 |
Why?
|
Immunity, Mucosal | 1 | 2013 | 490 | 0.020 |
Why?
|
Aluminum | 1 | 1990 | 152 | 0.020 |
Why?
|
Microinjections | 1 | 1990 | 327 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 1990 | 562 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 1998 | 1419 | 0.020 |
Why?
|
Intestinal Mucosa | 2 | 2013 | 3036 | 0.020 |
Why?
|
Intercellular Junctions | 1 | 1990 | 203 | 0.020 |
Why?
|
Fowlpox virus | 1 | 2009 | 20 | 0.020 |
Why?
|
Endopeptidases | 1 | 1993 | 772 | 0.020 |
Why?
|
Cell Compartmentation | 1 | 1990 | 402 | 0.020 |
Why?
|
Defective Viruses | 1 | 2009 | 112 | 0.020 |
Why?
|
Academies and Institutes | 1 | 2011 | 317 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2010 | 315 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2001 | 4456 | 0.020 |
Why?
|
Metaphase | 1 | 1989 | 151 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2716 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 1991 | 675 | 0.020 |
Why?
|
Insect Viruses | 1 | 1988 | 15 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 1988 | 248 | 0.020 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2008 | 67 | 0.020 |
Why?
|
Chemical Precipitation | 2 | 1986 | 179 | 0.020 |
Why?
|
Lepidoptera | 1 | 1988 | 23 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 1980 | 548 | 0.020 |
Why?
|
Immunoconjugates | 1 | 1995 | 901 | 0.020 |
Why?
|
Acute Disease | 5 | 2001 | 7149 | 0.020 |
Why?
|
DNA, Recombinant | 1 | 1988 | 476 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2183 | 0.020 |
Why?
|
Cholera Toxin | 1 | 1990 | 556 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 1998 | 2752 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1997 | 2107 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 1987 | 78 | 0.020 |
Why?
|
Comet Assay | 1 | 2007 | 71 | 0.020 |
Why?
|
Inositol | 1 | 1988 | 218 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2001 | 3265 | 0.020 |
Why?
|
Codon | 1 | 1989 | 611 | 0.020 |
Why?
|
Lymphoproliferative Disorders | 2 | 1982 | 523 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5535 | 0.020 |
Why?
|
DNA Restriction Enzymes | 1 | 1987 | 570 | 0.020 |
Why?
|
Viruses | 1 | 2010 | 374 | 0.020 |
Why?
|
Immunization, Secondary | 1 | 2009 | 340 | 0.020 |
Why?
|
HLA-B7 Antigen | 1 | 1986 | 48 | 0.020 |
Why?
|
Immunoglobulin M | 4 | 1993 | 1537 | 0.020 |
Why?
|
Electric Conductivity | 1 | 1987 | 411 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 20822 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2010 | 673 | 0.020 |
Why?
|
Models, Statistical | 1 | 2001 | 5102 | 0.020 |
Why?
|
Membrane Fluidity | 1 | 1986 | 73 | 0.020 |
Why?
|
Xenopus laevis | 1 | 1990 | 957 | 0.020 |
Why?
|
Cyclic AMP | 1 | 1990 | 1472 | 0.020 |
Why?
|
Prognosis | 1 | 2007 | 29063 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2008 | 981 | 0.020 |
Why?
|
Deoxyribonuclease I | 1 | 1987 | 229 | 0.020 |
Why?
|
Immunoglobulin alpha-Chains | 1 | 1985 | 8 | 0.020 |
Why?
|
Vaccines, Synthetic | 1 | 2009 | 634 | 0.020 |
Why?
|
Genome, Human | 2 | 2005 | 4420 | 0.020 |
Why?
|
Staphylococcus aureus | 2 | 1992 | 1451 | 0.020 |
Why?
|
Middle Aged | 21 | 2021 | 213383 | 0.020 |
Why?
|
Temperature | 1 | 1992 | 2206 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 1 | 1985 | 313 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 1988 | 769 | 0.020 |
Why?
|
Multigene Family | 1 | 1989 | 1102 | 0.020 |
Why?
|
Phorbols | 1 | 1985 | 43 | 0.020 |
Why?
|
Oocytes | 1 | 1990 | 1187 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 3 | 1987 | 3712 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18029 | 0.020 |
Why?
|
Markov Chains | 1 | 2008 | 969 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2000 | 5853 | 0.020 |
Why?
|
Electrophoresis | 1 | 1985 | 240 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 2 | 1992 | 3386 | 0.020 |
Why?
|
Horses | 3 | 1980 | 304 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2001 | 5708 | 0.020 |
Why?
|
Calcimycin | 1 | 1984 | 222 | 0.020 |
Why?
|
Gene Amplification | 1 | 1989 | 1063 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1987 | 575 | 0.020 |
Why?
|
Egtazic Acid | 1 | 1984 | 173 | 0.020 |
Why?
|
Oxygen | 1 | 2016 | 4189 | 0.020 |
Why?
|
DNA Replication | 1 | 1991 | 1399 | 0.020 |
Why?
|
Retroviridae Infections | 1 | 1985 | 151 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1157 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1989 | 1401 | 0.020 |
Why?
|
Carbohydrate Conformation | 2 | 1995 | 208 | 0.020 |
Why?
|
Cell Fractionation | 2 | 2002 | 252 | 0.020 |
Why?
|
RNA, Viral | 1 | 2013 | 2902 | 0.020 |
Why?
|
Burkitt Lymphoma | 2 | 1984 | 327 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1988 | 1572 | 0.020 |
Why?
|
Desmosomes | 1 | 1984 | 73 | 0.020 |
Why?
|
Colony-Stimulating Factors | 1 | 1984 | 221 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 1984 | 356 | 0.020 |
Why?
|
Carbohydrate Sequence | 2 | 1995 | 414 | 0.020 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 1984 | 173 | 0.020 |
Why?
|
Viral Load | 1 | 2013 | 3299 | 0.010 |
Why?
|
Cytosine | 1 | 2005 | 216 | 0.010 |
Why?
|
Moths | 1 | 2004 | 87 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.010 |
Why?
|
Autoradiography | 1 | 1985 | 745 | 0.010 |
Why?
|
Pollen | 1 | 1984 | 75 | 0.010 |
Why?
|
Solutions | 1 | 2004 | 426 | 0.010 |
Why?
|
Hemolytic Plaque Technique | 2 | 1982 | 66 | 0.010 |
Why?
|
Sjogren's Syndrome | 2 | 1985 | 233 | 0.010 |
Why?
|
Immunity | 1 | 2010 | 1012 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.010 |
Why?
|
Complement System Proteins | 3 | 1984 | 795 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1995 | 8301 | 0.010 |
Why?
|
Inflammation | 2 | 2019 | 10638 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1985 | 645 | 0.010 |
Why?
|
Mast Cells | 1 | 1991 | 1544 | 0.010 |
Why?
|
Tetanus Toxoid | 2 | 1981 | 193 | 0.010 |
Why?
|
Sequence Analysis, RNA | 1 | 2011 | 2012 | 0.010 |
Why?
|
Immunoglobulin Light Chains | 1 | 1984 | 277 | 0.010 |
Why?
|
Aging | 3 | 1996 | 8664 | 0.010 |
Why?
|
Ovary | 1 | 1988 | 981 | 0.010 |
Why?
|
Peanut Agglutinin | 1 | 1982 | 19 | 0.010 |
Why?
|
Interleukins | 1 | 1987 | 791 | 0.010 |
Why?
|
Pregnancy Trimester, Third | 1 | 1985 | 571 | 0.010 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2002 | 95 | 0.010 |
Why?
|
DNA Damage | 1 | 1992 | 2432 | 0.010 |
Why?
|
Granulocytes | 1 | 1984 | 548 | 0.010 |
Why?
|
Lymphatic System | 1 | 1984 | 253 | 0.010 |
Why?
|
Keratins | 1 | 1984 | 515 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1985 | 659 | 0.010 |
Why?
|
Prednisolone | 1 | 1983 | 334 | 0.010 |
Why?
|
Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 1981 | 7 | 0.010 |
Why?
|
Adolescent | 10 | 1985 | 85781 | 0.010 |
Why?
|
Thymus Neoplasms | 1 | 1984 | 268 | 0.010 |
Why?
|
Mitomycins | 1 | 1981 | 47 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 1987 | 987 | 0.010 |
Why?
|
Culture Media | 1 | 1984 | 908 | 0.010 |
Why?
|
Neurons | 1 | 2001 | 9338 | 0.010 |
Why?
|
Snails | 1 | 1981 | 22 | 0.010 |
Why?
|
IgA Deficiency | 1 | 1981 | 43 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2001 | 82 | 0.010 |
Why?
|
Antigens, Heterophile | 1 | 1982 | 69 | 0.010 |
Why?
|
Nitrobenzenes | 1 | 1981 | 65 | 0.010 |
Why?
|
Hypergammaglobulinemia | 1 | 1981 | 74 | 0.010 |
Why?
|
Anemia, Aplastic | 2 | 1984 | 226 | 0.010 |
Why?
|
Rats, Inbred SHR | 1 | 2001 | 195 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 1983 | 741 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1985 | 1032 | 0.010 |
Why?
|
Lepromin | 1 | 1980 | 8 | 0.010 |
Why?
|
Interleukin-6 | 1 | 1991 | 3200 | 0.010 |
Why?
|
ROC Curve | 1 | 2008 | 3527 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 1987 | 2879 | 0.010 |
Why?
|
Antigens, Ly | 1 | 2001 | 291 | 0.010 |
Why?
|
Capsid Proteins | 1 | 2004 | 479 | 0.010 |
Why?
|
Primates | 1 | 1983 | 545 | 0.010 |
Why?
|
Child | 14 | 1984 | 77709 | 0.010 |
Why?
|
Leprosy | 1 | 1980 | 124 | 0.010 |
Why?
|
Chimera | 1 | 2001 | 485 | 0.010 |
Why?
|
Syndrome | 2 | 1984 | 3251 | 0.010 |
Why?
|
Mycosis Fungoides | 1 | 1981 | 163 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2012 | 3597 | 0.010 |
Why?
|
Leukemia, Myeloid | 1 | 1983 | 707 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2001 | 772 | 0.010 |
Why?
|
Eosinophils | 1 | 1984 | 955 | 0.010 |
Why?
|
Agranulocytosis | 1 | 1979 | 101 | 0.010 |
Why?
|
Fibroblasts | 2 | 1988 | 4161 | 0.010 |
Why?
|
Isoantibodies | 2 | 1981 | 679 | 0.010 |
Why?
|
Polymers | 1 | 1986 | 1621 | 0.010 |
Why?
|
Pregnancy | 3 | 1993 | 29144 | 0.010 |
Why?
|
Sarcoma, Kaposi | 1 | 1982 | 370 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2001 | 844 | 0.010 |
Why?
|
Blood Circulation | 1 | 1999 | 251 | 0.010 |
Why?
|
Intestines | 1 | 1988 | 1924 | 0.010 |
Why?
|
Phylogeny | 2 | 2002 | 2803 | 0.010 |
Why?
|
Antibodies, Neoplasm | 1 | 1980 | 286 | 0.010 |
Why?
|
Endocytosis | 1 | 2003 | 985 | 0.010 |
Why?
|
Bone Marrow | 3 | 1984 | 2948 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9313 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2000 | 381 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40561 | 0.010 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2001 | 475 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1982 | 1263 | 0.010 |
Why?
|
Aged | 8 | 2019 | 163280 | 0.010 |
Why?
|
Kidney Transplantation | 2 | 1983 | 4251 | 0.010 |
Why?
|
Stress, Physiological | 1 | 1985 | 1403 | 0.010 |
Why?
|
Fluorescence | 1 | 1980 | 751 | 0.010 |
Why?
|
Transplantation, Homologous | 3 | 1983 | 4776 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1983 | 2242 | 0.010 |
Why?
|
Nucleotidyltransferases | 1 | 1979 | 220 | 0.010 |
Why?
|
Receptors, Interleukin-12 | 1 | 1996 | 26 | 0.010 |
Why?
|
Antigens, T-Independent | 1 | 1996 | 21 | 0.010 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 1982 | 546 | 0.010 |
Why?
|
Gestational Age | 1 | 1985 | 3493 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2008 | 3589 | 0.010 |
Why?
|
Biosensing Techniques | 1 | 2002 | 668 | 0.010 |
Why?
|
Erythropoiesis | 1 | 1980 | 705 | 0.010 |
Why?
|
Infant, Premature | 1 | 1985 | 2044 | 0.010 |
Why?
|
Biological Transport | 1 | 2000 | 2118 | 0.010 |
Why?
|
Erythropoietin | 1 | 1980 | 726 | 0.010 |
Why?
|
Receptors, Interleukin | 1 | 1996 | 245 | 0.010 |
Why?
|
Mitosis | 1 | 1980 | 1208 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56430 | 0.010 |
Why?
|
Leukopenia | 2 | 1985 | 212 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1979 | 1276 | 0.010 |
Why?
|
Acetylglucosamine | 1 | 1995 | 191 | 0.010 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 1986 | 349 | 0.010 |
Why?
|
Protein Kinases | 1 | 2000 | 1640 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 9239 | 0.010 |
Why?
|
Cell Survival | 1 | 1982 | 5882 | 0.010 |
Why?
|
Drosophila | 1 | 1999 | 1491 | 0.010 |
Why?
|
Cyclosporins | 1 | 1991 | 220 | 0.010 |
Why?
|
Sepharose | 1 | 1991 | 108 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 1984 | 2957 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1992 | 898 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1992 | 768 | 0.010 |
Why?
|
Thrombocytopenia | 3 | 1985 | 1179 | 0.010 |
Why?
|
Brain | 5 | 1983 | 26385 | 0.010 |
Why?
|
Serum Albumin, Bovine | 2 | 1981 | 324 | 0.010 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1990 | 87 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2001 | 3508 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1983 | 4149 | 0.010 |
Why?
|
X-Ray Diffraction | 1 | 1990 | 420 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1980 | 2942 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1980 | 1622 | 0.010 |
Why?
|
Ovalbumin | 2 | 1981 | 719 | 0.010 |
Why?
|
Homeostasis | 1 | 1980 | 3340 | 0.010 |
Why?
|
Oligodendroglia | 2 | 1983 | 517 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1993 | 1213 | 0.010 |
Why?
|
Infant, Newborn | 2 | 1985 | 25625 | 0.000 |
Why?
|
Particle Accelerators | 1 | 1987 | 173 | 0.000 |
Why?
|
Pattern Recognition, Automated | 1 | 1993 | 1005 | 0.000 |
Why?
|
Plant Lectins | 1 | 1986 | 104 | 0.000 |
Why?
|
Fabaceae | 1 | 1986 | 103 | 0.000 |
Why?
|
Plants, Medicinal | 1 | 1986 | 167 | 0.000 |
Why?
|
Deltaretrovirus | 1 | 1985 | 170 | 0.000 |
Why?
|
Dinitrophenols | 1 | 1984 | 57 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1987 | 1681 | 0.000 |
Why?
|
Chronic Disease | 1 | 1979 | 9146 | 0.000 |
Why?
|
gamma-Globulins | 1 | 1983 | 124 | 0.000 |
Why?
|
Xerostomia | 1 | 1984 | 95 | 0.000 |
Why?
|
Aotus trivirgatus | 1 | 1983 | 37 | 0.000 |
Why?
|
Chromosomes, Human, 21-22 and Y | 1 | 1983 | 46 | 0.000 |
Why?
|
Lemur | 1 | 1983 | 5 | 0.000 |
Why?
|
Skin Ulcer | 1 | 1984 | 120 | 0.000 |
Why?
|
Immunologic Techniques | 1 | 1983 | 218 | 0.000 |
Why?
|
Random Allocation | 1 | 1987 | 2429 | 0.000 |
Why?
|
Saimiri | 1 | 1983 | 330 | 0.000 |
Why?
|
Histocytochemistry | 1 | 1983 | 719 | 0.000 |
Why?
|
Convalescence | 1 | 1982 | 105 | 0.000 |
Why?
|
Herpes Zoster | 1 | 1984 | 264 | 0.000 |
Why?
|
Borohydrides | 1 | 1981 | 32 | 0.000 |
Why?
|
Periodic Acid | 1 | 1981 | 19 | 0.000 |
Why?
|
Galactose Oxidase | 1 | 1981 | 14 | 0.000 |
Why?
|
Chickens | 1 | 1983 | 865 | 0.000 |
Why?
|
Radioimmunoassay | 1 | 1981 | 919 | 0.000 |
Why?
|
Mycobacterium leprae | 1 | 1980 | 94 | 0.000 |
Why?
|
Central Nervous System Diseases | 1 | 1985 | 518 | 0.000 |
Why?
|
Muscular Diseases | 1 | 1985 | 556 | 0.000 |
Why?
|
Neuraminidase | 1 | 1981 | 210 | 0.000 |
Why?
|
Capillaries | 1 | 1983 | 773 | 0.000 |
Why?
|
Splenectomy | 1 | 1981 | 395 | 0.000 |
Why?
|
Leukemia, Experimental | 1 | 1979 | 246 | 0.000 |
Why?
|
Prednisone | 1 | 1984 | 1574 | 0.000 |
Why?
|
Autopsy | 1 | 1983 | 1020 | 0.000 |
Why?
|
Hypothyroidism | 1 | 1984 | 658 | 0.000 |
Why?
|
Cell Count | 1 | 1983 | 1856 | 0.000 |
Why?
|
Plasmacytoma | 1 | 1979 | 183 | 0.000 |
Why?
|
Drug Resistance | 1 | 1984 | 1609 | 0.000 |
Why?
|
Neuroglia | 1 | 1983 | 927 | 0.000 |
Why?
|
Twins, Monozygotic | 1 | 1979 | 458 | 0.000 |
Why?
|
Blood Transfusion | 1 | 1984 | 1301 | 0.000 |
Why?
|
Radiotherapy | 1 | 1984 | 1533 | 0.000 |
Why?
|
Mediastinal Neoplasms | 1 | 1980 | 423 | 0.000 |
Why?
|
Antibodies, Bacterial | 1 | 1981 | 1470 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1987 | 8642 | 0.000 |
Why?
|
Aorta | 1 | 1983 | 2061 | 0.000 |
Why?
|
Lung Diseases | 1 | 1985 | 1886 | 0.000 |
Why?
|
Follow-Up Studies | 2 | 1987 | 39050 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1985 | 2149 | 0.000 |
Why?
|
Tissue Donors | 1 | 1979 | 2240 | 0.000 |
Why?
|
Age Factors | 1 | 1983 | 18370 | 0.000 |
Why?
|
Skin | 1 | 1979 | 4364 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1982 | 20129 | 0.000 |
Why?
|